Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
Gladys Telliam(Inserm), Ali G. Turhan(Inserm), Estelle Balducci(Hôpital Necker-Enfants Malades), Hervé Acloque(AgroParisTech), Noufϊssa Oudrhiri(Inserm), Jusuf Imeri(Inserm), Annelise Bennaceur‐Griscelli(Inserm), Micheline Fontaine-Arnoux(Assistance Publique – Hôpitaux de Paris), Christophe Desterke(Université Paris-Saclay), Radhia M’kacher(Genopole (France))
Cited by 12
Related Papers
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
|Journal of Clinical Investigation|2009|1.4k
Serum 2-Hydroxyglutarate Production in <i>IDH1</i>- and <i>IDH2</i>-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
|Journal of Clinical Oncology|2013|117
Telomere Shortening and Associated Chromosomal Instability in Peripheral Blood Lymphocytes of Patients With Hodgkin’s Lymphoma Prior to Any Treatment Are Predictive of Second Cancers
|International Journal of Radiation Oncology*Biology*Physics|2007|68
New tool for biological dosimetry: Reevaluation and automation of the gold standard method following telomere and centromere staining
|Mutation research. Fundamental and molecular mechanisms of mutagenesis|2014|65
Integration of new biological and physical retrospective dosimetry methods into EU emergency response plans – joint RENEB and EURADOS inter-laboratory comparisons
|International Journal of Radiation Biology|2016|63